Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
2002 1
2005 1
2006 1
2007 5
2008 4
2009 3
2010 1
2011 3
2012 2
2013 3
2014 5
2015 5
2016 1
2017 3
2018 3
2019 7
2020 7
2021 7
2022 4
2023 8
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

69 results

Results by year

Filters applied: . Clear all
Page 1
Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial.
Mok TSK, Wu YL, Kudaba I, Kowalski DM, Cho BC, Turna HZ, Castro G Jr, Srimuninnimit V, Laktionov KK, Bondarenko I, Kubota K, Lubiniecki GM, Zhang J, Kush D, Lopes G; KEYNOTE-042 Investigators. Mok TSK, et al. Lancet. 2019 May 4;393(10183):1819-1830. doi: 10.1016/S0140-6736(18)32409-7. Epub 2019 Apr 4. Lancet. 2019. PMID: 30955977 Clinical Trial.
Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC.
Socinski MA, Jotte RM, Cappuzzo F, Orlandi F, Stroyakovskiy D, Nogami N, Rodríguez-Abreu D, Moro-Sibilot D, Thomas CA, Barlesi F, Finley G, Kelsch C, Lee A, Coleman S, Deng Y, Shen Y, Kowanetz M, Lopez-Chavez A, Sandler A, Reck M; IMpower150 Study Group. Socinski MA, et al. N Engl J Med. 2018 Jun 14;378(24):2288-2301. doi: 10.1056/NEJMoa1716948. Epub 2018 Jun 4. N Engl J Med. 2018. PMID: 29863955 Free article. Clinical Trial.
Alectinib versus Crizotinib in Untreated ALK-Positive Non-Small-Cell Lung Cancer.
Peters S, Camidge DR, Shaw AT, Gadgeel S, Ahn JS, Kim DW, Ou SI, Pérol M, Dziadziuszko R, Rosell R, Zeaiter A, Mitry E, Golding S, Balas B, Noe J, Morcos PN, Mok T; ALEX Trial Investigators. Peters S, et al. N Engl J Med. 2017 Aug 31;377(9):829-838. doi: 10.1056/NEJMoa1704795. Epub 2017 Jun 6. N Engl J Med. 2017. PMID: 28586279 Free article. Clinical Trial.
First-line crizotinib versus chemotherapy in ALK-positive lung cancer.
Solomon BJ, Mok T, Kim DW, Wu YL, Nakagawa K, Mekhail T, Felip E, Cappuzzo F, Paolini J, Usari T, Iyer S, Reisman A, Wilner KD, Tursi J, Blackhall F; PROFILE 1014 Investigators. Solomon BJ, et al. N Engl J Med. 2014 Dec 4;371(23):2167-77. doi: 10.1056/NEJMoa1408440. N Engl J Med. 2014. PMID: 25470694 Free article. Clinical Trial.
WITHDRAWN: Revista Portuguesa de Pneumologia: Ano em Revisão 2010.
Domingos A, Cardoso J, Azevedo I, Barata F, Ferreira J, Cordeiro CR. Domingos A, et al. Among authors: barata f. Rev Port Pneumol. 2011 Oct 26. doi: 10.1016/j.rppneu.2011.09.003. Online ahead of print. Rev Port Pneumol. 2011. PMID: 22032990 Free article. English, Portuguese. No abstract available.
Greek Gods and Portuguese Pneumology: implementing HERMES.
Alfaro T, Barata F, Elphinstone M, Sutter S, Santos S, Mitchell S, Maciel R, Casas A, Migliori GB, Cordeiro CR. Alfaro T, et al. Among authors: barata f. Rev Port Pneumol (2006). 2015 Nov-Dec;21(6):291-2. doi: 10.1016/j.rppnen.2015.10.003. Rev Port Pneumol (2006). 2015. PMID: 26653070 No abstract available.
18F-FDG PET/CT in lung cancer. The added value of quantification.
Lapa P, Marques M, Isidoro J, Barata F, Costa G, de Lima JP. Lapa P, et al. Among authors: barata f. Rev Esp Med Nucl Imagen Mol. 2017 Nov-Dec;36(6):342-349. doi: 10.1016/j.remn.2017.04.001. Epub 2017 May 27. Rev Esp Med Nucl Imagen Mol. 2017. PMID: 28566260 English, Spanish.
69 results